RxDoctor Payments Data

Dustin Hyatt, MD

Urology · Florence, ALNPI 1528389517

Payments from drug & device makers

$2,160in general payments, 2019–2025

Across 29 payments — averaging $74.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Intuitive Surgical$742
  • Astellas Pharma US Inc$97
  • Antares Pharma, Inc.$78
  • Tolmar Pharmaceuticals, Inc.$45
  • Immunitybio, Inc.$41
  • plus $146 from 6 others

What the payments were for

  • Travel & lodging$73634%
  • Food & beverage$85940%
  • Education$56526%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,160 in reported general payments places this provider in the 35th percentile of 179 urology providers in Alabama.

See all urology providers in Alabama

Medicare billing

Part B allowed, 2024
$169,865
Medicare patients
599
Services billed
3,343

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide25$473,731
GemtesaVibegron67$48,797
MyrbetriqMirabegron58$26,266
Tamsulosin Hcl844$13,655
Testosterone Cypionate215$6,941
Finasteride420$6,880
Tolterodine Tartrate44$6,856
Testosterone29$4,539
Tolterodine Tartrate ErTolterodine Tartrate26$3,450
Oxybutynin Chloride132$2,961
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst57$2,783
Oxybutynin Chloride ErOxybutynin Chloride60$1,991
Estradiol20$1,267
Terazosin Hcl47$1,051
Alfuzosin Hcl ErAlfuzosin Hcl14$519

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncXtandi, Myrbetriq$97$499,99783 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 179 urology providers in Alabama.

Other urology in Florence

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →